Tyrosine kinase inhibitors

From Libre Pathology
Revision as of 16:13, 29 March 2012 by Michael (talk | contribs) (create)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Tyrosine kinase inhibitors, abbreviated TKIs, are a group of drugs that inhibit the action of tyrosine kinases.

The category includes many cancer drugs - including:

  • Imatinib (Gleevec).
  • Gefitinib (Iressa).
  • Erlotinib (Tarceva).

See also

Retrieved from "https://librepathology.org/w/index.php?title=Tyrosine_kinase_inhibitors&oldid=14289"